ELYM Relative Valuation - Eliem Therapeutics Inc - Alpha Spread

Eliem Therapeutics Inc
NASDAQ:ELYM

Watchlist Manager
Eliem Therapeutics Inc Logo
Eliem Therapeutics Inc
NASDAQ:ELYM
Watchlist
Price: 8.28 USD 3.76% Market Closed
Market Cap: 553m USD
Have any thoughts about
Eliem Therapeutics Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of ELYM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ELYM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
23.7
Forward
-15.6
vs History
0
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
22.3
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-2.6
Industry
24.8
vs History
5
vs Industry
20
Median 3Y
0.7
Median 5Y
0.7
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
vs Industry
18
Median 3Y
0.7
Median 5Y
0.7
Industry
4.8
vs History
vs Industry
17
Median 3Y
0.7
Median 5Y
0.7
Industry
4.5
Forward
-9.3
vs History
0
vs Industry
21
Median 3Y
0.8
Median 5Y
0.8
Industry
6.4
vs History
vs Industry
17
Median 3Y
0.7
Median 5Y
0.7
Industry
4.4
vs History
2
vs Industry
3
Median 3Y
-1.6
Median 5Y
-1.6
Industry
4.8

Multiples Across Competitors

ELYM Competitors Multiples
Eliem Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eliem Therapeutics Inc
NASDAQ:ELYM
553m USD 0 -8.6 -4.7 -4.7
US
Abbvie Inc
NYSE:ABBV
341.7B USD 6.2 64.5 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
181.2B USD 5.9 57.9 20.2 36.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
126.5B USD 9.4 29.3 25.7 28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD 11.6 -245 26 27.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
US
Gilead Sciences Inc
NASDAQ:GILD
103.6B USD 3.7 98.4 9.4 11.9
AU
CSL Ltd
ASX:CSL
141.9B AUD 6.5 36.6 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.1B USD 15 -480.9 211.7 325.8
P/E Multiple
Earnings Growth
US
Eliem Therapeutics Inc
NASDAQ:ELYM
Average P/E: 57.3
Negative Multiple: -8.6
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.9
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.3
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -245
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
98.4
71%
AU
CSL Ltd
ASX:CSL
36.6
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -480.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Eliem Therapeutics Inc
NASDAQ:ELYM
Average EV/EBITDA: 47.3
Negative Multiple: -4.7
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.7
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
39%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
211.7
N/A
EV/EBIT Multiple
EBIT Growth
US
Eliem Therapeutics Inc
NASDAQ:ELYM
Average EV/EBIT: 68.9
Negative Multiple: -4.7
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.7
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.4
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.3
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
11.9
26%
AU
CSL Ltd
ASX:CSL
27.9
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
325.8
N/A

See Also

Discover More
Back to Top